JP2011507859A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011507859A5 JP2011507859A5 JP2010539516A JP2010539516A JP2011507859A5 JP 2011507859 A5 JP2011507859 A5 JP 2011507859A5 JP 2010539516 A JP2010539516 A JP 2010539516A JP 2010539516 A JP2010539516 A JP 2010539516A JP 2011507859 A5 JP2011507859 A5 JP 2011507859A5
- Authority
- JP
- Japan
- Prior art keywords
- connexin
- composition
- polynucleotide
- oligonucleotide
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US874807P | 2007-12-21 | 2007-12-21 | |
| PCT/US2008/014024 WO2009085273A2 (en) | 2007-12-21 | 2008-12-22 | Use of anti-connexin polynucleotides for the treatment of surgical adhesions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014173528A Division JP2015013880A (ja) | 2007-12-21 | 2014-08-28 | 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011507859A JP2011507859A (ja) | 2011-03-10 |
| JP2011507859A5 true JP2011507859A5 (https=) | 2013-04-25 |
Family
ID=40824957
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010539516A Pending JP2011507859A (ja) | 2007-12-21 | 2008-12-22 | 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用 |
| JP2014173528A Pending JP2015013880A (ja) | 2007-12-21 | 2014-08-28 | 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014173528A Pending JP2015013880A (ja) | 2007-12-21 | 2014-08-28 | 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110144182A1 (https=) |
| EP (1) | EP2252689A2 (https=) |
| JP (2) | JP2011507859A (https=) |
| AU (1) | AU2008343754A1 (https=) |
| CA (1) | CA2710227A1 (https=) |
| WO (1) | WO2009085273A2 (https=) |
| ZA (1) | ZA201005220B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102073629B1 (ko) | 2005-02-03 | 2020-02-05 | 코다 테라퓨틱스 (엔지) 리미티드 | 항-코넥신 화합물 및 그의 용도 |
| US8975237B2 (en) | 2007-12-21 | 2015-03-10 | Coda Therapeutics, Inc. | Treatment of fibrotic conditions |
| EP2558107B1 (en) * | 2010-04-13 | 2018-07-11 | KCI Licensing, Inc. | Compositions with reactive ingredients, and wound dressings, apparatuses, and methods |
| DK2819682T3 (en) | 2012-03-01 | 2017-08-21 | Firststring Res Inc | TOPICAL GELLS CONTAINING ALPHA-CONNEXIN C-TERMINAL (ACT) PEPTIDES |
| WO2013148736A1 (en) | 2012-03-27 | 2013-10-03 | Coda Therapeutics, Inc. | Compositions and treatments based on cadherin modulation |
| EP2852401A4 (en) * | 2012-04-02 | 2015-11-11 | Univ Saint Louis | METHOD AND COMPOSITIONS FOR REDUCING THE POSTSURFACE OF POST-SURGICAL TERMINATION |
| CN107109410B (zh) | 2014-08-22 | 2021-11-02 | 奥克兰联合服务有限公司 | 通道调节剂 |
| CA3061738A1 (en) | 2017-04-28 | 2018-11-01 | Auckland Uniservices Limited | Methods of treatment and novel constructs |
| MX2023004631A (es) | 2020-10-22 | 2023-07-20 | Xequel Bio Inc | Formulaciones peptidicas y usos oftalmicos de las mismas. |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3687808A (en) * | 1969-08-14 | 1972-08-29 | Univ Leland Stanford Junior | Synthetic polynucleotides |
| US5034506A (en) * | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| CA1322714C (en) * | 1986-11-14 | 1993-10-05 | Harry N. Antoniades | Wound healing and bone regeneration |
| JPH0539594Y2 (https=) * | 1988-08-05 | 1993-10-07 | ||
| US5166195A (en) * | 1990-05-11 | 1992-11-24 | Isis Pharmaceuticals, Inc. | Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides |
| US6752987B1 (en) * | 1995-02-28 | 2004-06-22 | The Regents Of The University Of California | Adenovirus encoding human adenylylcyclase (AC) VI |
| US20030148968A1 (en) * | 1995-02-28 | 2003-08-07 | Hammond H. Kirk | Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| AU9016898A (en) * | 1997-08-07 | 1999-03-01 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Methods and compositions for treatment of restenosis |
| WO1999029858A1 (en) * | 1997-12-09 | 1999-06-17 | Children's Medical Center Corporation | Soluble inhibitors of vascular endothelial growth factor and use thereof |
| US6506559B1 (en) * | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| EP2314321B1 (en) * | 1999-01-27 | 2014-06-04 | Coda Therapeutics, Inc. | Formulations comprising antisense nucleotides to connexins |
| US5998148A (en) * | 1999-04-08 | 1999-12-07 | Isis Pharmaceuticals Inc. | Antisense modulation of microtubule-associated protein 4 expression |
| CA2425662A1 (en) * | 2000-10-18 | 2002-04-25 | Children's Medical Center Corporation | Osteopontin-coated surfaces and methods of use |
| US20050119211A1 (en) * | 2001-05-18 | 2005-06-02 | Sirna Therapeutics, Inc. | RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA) |
| JP2005509621A (ja) * | 2001-10-17 | 2005-04-14 | ユニバーシティ オブ ウェールズ カレッジ オブ メディスン | ギャップ結合ならびにｅｄｈｆ |
| CN1638790A (zh) * | 2002-01-29 | 2005-07-13 | Wyeth公司 | 用于调节连接蛋白半通道的组合物和方法 |
| WO2003096981A2 (en) * | 2002-05-15 | 2003-11-27 | Seul, Kyung, Hwan | Method of modulating angiogenesis |
| US8809504B2 (en) * | 2002-09-03 | 2014-08-19 | Vit Lauermann | Inhibitor which is deactivatable by a reagent produced by a target cell |
| WO2006006948A2 (en) * | 2002-11-14 | 2006-01-19 | Dharmacon, Inc. | METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY |
| KR101350837B1 (ko) * | 2003-12-03 | 2014-01-14 | 코다 테라퓨틱스, 인크. | 코넥신에 표적화된 안티센스 화합물 및 그의 사용 방법 |
| ES2729826T3 (es) * | 2004-09-23 | 2019-11-06 | Arc Medical Devices Inc | Composiciones farmacéuticas y métodos relacionados para inhibir adherencias fibrosas o enfermedad inflamatoria usando fucanos con bajo contenido de sulfato |
| KR102073629B1 (ko) * | 2005-02-03 | 2020-02-05 | 코다 테라퓨틱스 (엔지) 리미티드 | 항-코넥신 화합물 및 그의 용도 |
| KR20080088600A (ko) * | 2005-12-16 | 2008-10-02 | 아를라 푸즈 에이엠비에이 | 상처 치유 방법의 개선을 위한 소 오스테오폰틴 제제 |
| AU2008223817A1 (en) * | 2007-03-02 | 2008-09-12 | National University Of Ireland, Galway | Osteopontin for the prediction and treatment of cardiovascular diseases |
| EP2245158A2 (en) * | 2007-12-11 | 2010-11-03 | Coda Therapeutics, Inc. | Impaired wound healing compositions and treatments |
-
2008
- 2008-12-22 JP JP2010539516A patent/JP2011507859A/ja active Pending
- 2008-12-22 CA CA2710227A patent/CA2710227A1/en not_active Abandoned
- 2008-12-22 WO PCT/US2008/014024 patent/WO2009085273A2/en not_active Ceased
- 2008-12-22 AU AU2008343754A patent/AU2008343754A1/en not_active Abandoned
- 2008-12-22 US US12/809,933 patent/US20110144182A1/en not_active Abandoned
- 2008-12-22 EP EP08866069A patent/EP2252689A2/en not_active Withdrawn
-
2010
- 2010-07-21 ZA ZA2010/05220A patent/ZA201005220B/en unknown
-
2014
- 2014-08-28 JP JP2014173528A patent/JP2015013880A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011507859A5 (https=) | ||
| JP5607176B2 (ja) | 新規ペプチドおよびその用途 | |
| US8668703B2 (en) | Medical devices incorporating collagen inhibitors | |
| US20090180965A1 (en) | Methods for repair and regeneration of bone marrow | |
| JP4307561B2 (ja) | 創傷の治癒 | |
| JP2011507858A5 (https=) | ||
| US9782522B2 (en) | Compositions and methods for treating and preventing neointimal stenosis | |
| JP2011507599A5 (https=) | ||
| JP2011507855A5 (https=) | ||
| KR20120014251A (ko) | 동종이식편의 접합을 개선하기 위한 생체활성 코팅 조성물 및 방법 | |
| Hildebrand et al. | Joint capsule matrix turnover in a rabbit model of chronic joint contractures: correlation with human contractures | |
| CN105078889B (zh) | 一种用于治疗软骨疾病的脂质体递送系统及其制备方法 | |
| DE602005025347D1 (de) | Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten | |
| WO2013059879A1 (en) | Compositions and methods for the treatment of fibrosis and fibrotic diseases | |
| KR20240105439A (ko) | 건-골 계면의 복구를 위한 방법 및 조성물 | |
| JP7129399B2 (ja) | 哺乳動物における滑膜炎の予防および／または治療に使用するためのポリアクリルアミドヒドロゲル | |
| TW201023879A (en) | Method of inhibiting and/or rescuing cell terminal differentiation, and composition for treating and/or inhibiting arthritis | |
| JP7514563B2 (ja) | オルガノイドおよび抗炎症剤を含む炎症性腸疾患の予防または治療用薬学組成物 | |
| EA020344B1 (ru) | Средство для профилактики и лечения острого и хронического панкреатита | |
| US20180214388A1 (en) | Composition and method for reducing scarring | |
| Meisel et al. | Sunitinib inhibits postoperative adhesions in a rabbit model | |
| CN104644620B (zh) | 化合物xl‑001在制备治疗慢性肾脏病的药物中的用途 | |
| CN115120729B (zh) | 跨膜蛋白41b作为药物靶标在制备治疗病理性心肌肥厚药物中的应用 | |
| CN118217295A (zh) | 25-羟基胆固醇在制备骨质疏松和骨溶解症治疗药物中的应用 | |
| RU2010144554A (ru) | Средство для предотвращения и/или лечения сосудистых заболеваний |